# Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.

> **NCT07439172** · PHASE2 · NOT_YET_RECRUITING · sponsor: **The Cooper Health System** · enrollment: 70 (estimated)

## Conditions studied

- High Grade Gliomas
- Glioblastoma
- Astrocytoma
- Oligodendroglioma

## Interventions

- **DRUG:** Pre-radiation temozolomide.

## Key facts

- **NCT ID:** NCT07439172
- **Lead sponsor:** The Cooper Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2028-09
- **Final completion:** 2029-09
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07439172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07439172, "Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07439172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*